Loss of enteral nutrition in a mouse model results in intestinal epithelial barrier dysfunction

Annals of the New York Academy of Sciences

Volumn 1258, Issue 1, 2012, Pages 71-77

  Feng, Yongjia ^a   Ralls, Matthew W ^a   Xiao, Weidong ^a   Miyasaka, Eiichi ^a   Herman, Richard S ^a   Teitelbaum, Daniel H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Epithelial barrier function; P Akt; Parenteral nutrition; Small intestine

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GLUTAMIC ACID; GLUTAMINE; PROTEIN KINASE B; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; DOWN REGULATION; EPITHELIUM CELL; HUMAN; INTESTINE ABSORPTION; INTESTINE EPITHELIUM; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; MICROBIOME; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TIGHT JUNCTION; TOTAL PARENTERAL NUTRITION; UPREGULATION;

EID: 84862836971     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06572.x     Document Type: Article

References (54)

1. Braga, M. et al 2009. ESPEN Guidelines on Parenteral Nutrition: surgery. Clin. Nutr. 28: 378-386.
2. Duro, D., D. Kamin & C. Duggan 2008. Overview of pediatric short bowel syndrome. J. Pediatr. Gastroenterol Nutr. 47(Suppl. 1): S33-S36.
3. Spencer, A. et al 2005. Mortality and outcomes of pediatric short bowel syndrome: redefining predictors of success. Ann. Surg. 242: 1-10.
4. Gogos, C.A. & F. Kalfarentzos 1995. Total parenteral nutrition and immune system activity: a review. Nutrition 11: 339-344.
5. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. 1991. Perioperative total parenteral nutrition in surgical patients. N. Engl. J. Med. 325: 525-532.
6. Wildhaber, B.E. et al 2002. TPN-induced apoptosis in mouse intestinal epithelium: regulation by the BCL-2 protein family. Ped. Surg. Int. 18: 570-575.
7. Yang, H. et al 2002. Interferon-gamma expression by intraepithelial lymphocytes results in a loss of epithelial barrier function in a mouse model of total parenteral nutrition. Ann. Surg. 236: 226-234.
8. Feng, Y. & D.H. Teitelbaum 2012. Epidermal growth factor/TNF-alpha transactivation modulates epithelial cell proliferation and apoptosis in a mouse model of parenteral nutrition. Am. J. Physiol. Gastrointest Liver Physiol 302: G236-G249.
9. Yang, H. & D.H. Teitelbaum 2003. Intraepithelial lymphocyte-derived interferon-gamma evokes enterocyte apoptosis with parenteral nutrition in mice. Am. J. Physiol. Gastrointest Liver Physiol. 284: G629-G637.
10. Li, J. et al 1995. Effect of parenteral and enteral nutrition on gut-associated lymphoid tissue. J. Trauma 39: 44-51.
11. Feng, Y., J.E. McDunn & D.H. Teitelbaum 2010. Decreased phospho-Akt signaling in a mouse model of total parenteral nutrition: a potential mechanism for the development of intestinal mucosal atrophy. Am. J. Physiol. Gastrointest Liver Physiol. 298: G833-G841.
12. Sun, X. et al 2008. Decline in intestinal mucosal IL-10 expression and decreased intestinal barrier function in a mouse model of total parenteral nutrition. Am. J. Physiol. Gastrointest Liver Physiol. 294: G139-G147 PMID: 17991705.
13. Feng, Y. et al 2009. Dissociation of E-Cadherin and beta-catenin in a mouse model of total parenteral nutrition: a mechanism for the loss of epithelial cell proliferation and villus atrophy. J. Physiol. (London) 587: 641-654.
14. Miyasaka, E. et al 2011. Total parenteral nutrition (TPN) in a mouse model leads to major population shifts in the intestinal microbiome. Gastroenterology 140: 1.
15. Miyasaka, E. et al 2010. Removal of enteral nutrition with total parenteral nutrition in mice leads to changes in bacterial flora and an associated increased toll-like receptors in the small intestinal lamina propria. Gastroenterology 138: S-608-S-609.
16. Miyasaka, E. & D. Teitelbaum 2010. Loss of small-intestine lamina propria T-regulatory cells in a mouse-model of total parenteral nutrition (TPN). J. Surg. Res. 158: 330.
17. Miyasaka, E., Y. Feng & D. Teitelbaum 2011. Total Parenteral nutrition in a mouse model results in a proinflammatory state in the lamina propria: a Myd88-dependent mechanisms of action [abstract]. Surgery In press.
18. McElroy, S.J. et al 2008. Tumor necrosis factor inhibits ligand-stimulated EGF receptor activation through a TNF receptor 1-dependent mechanism. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G285-G293.
19. Yamaoka, T. et al 2008. Transactivation of EGF receptor and ErbB2 protects intestinal epithelial cells from TNF-induced apoptosis. Proc. Natl. Acad. Sci. USA 105: 11772-11777.
20. Yang, H. et al 2004. Intestinal intraepithelial lymphocyte gamma delta-T cell-derived keratinocyte growth factor modulates epithelial growth in the mouse. J. Immunol. 172: 4151-4158.
21. Yang, H., B.E. Wildhaber & D.H. Teitelbaum 2003. Keratinocyte growth factor improves epithelial function after massive small bowel resection. J. Parenter Enteral Nutr. 27: 198-206.
22. Yang, H. et al 2002. 2002 Harry M. Vars Research Award. Keratinocyte growth factor stimulates the recovery of epithelial structure and function in a mouse model of total parenteral nutrition. JPEN J. Parenter Enteral Nutr. 26: 333-340; discussion 340-331.
23. Feng, Y., J. Holst & D. Teitelbaum 2011. Total parenteral nutrition (TPN)-associated atrophy is associated with loss of intestinal epithelial cell (EC) migration: modulation of action by epidermal growth factor (EGF) and glucagon-like peptide-2(GLP-2). Gastroenterology 140: S-170-S-171.
24. Tsai, C., M. Hill & K. Drucker 1997. Biological determinants of intestinotrophic properties of GLP-2 in vivo. Am. J. Physiol. 272: G662-G668.
25. Brubaker, P. et al 1997. Circulating and tissue forms of the intestinal growth factor, glucagon-like peptide-2. Endocrinology 138: 4837-4843.
26. Yang, H., R. Finaly & D.H. Teitelbaum 2003. Alteration in epithelial permeability and ion transport in a mouse model of total parenteral nutrition. Crit. Care Med. 31: 1118-1125.
27. Kudsk, K.A. et al 1992. Enteral versus parenteral feeding. Effects on septic morbidity after blunt and penetrating abdominal trauma. Ann. Surg. 215: 503-511; discussion 511-503.
28. Kiristioglu, I. et al 2002. Total parenteral nutrition-associated changes in mouse intestinal intraepithelial lymphocytes. Dig. Dis. Sci. 47: 1147-1157.
29. Kiristioglu, I. & D.H. Teitelbaum 1998. Alteration of the intestinal intraepithelial lymphocytes during total parenteral nutrition. J. Surg. Res. 79: 91-96.
30. Clayburgh, D.R., L. Shen & J.R. Turner 2004. A porous defense: the leaky epithelial barrier in intestinal disease. Lab Invest. 84: 282-291.
31. Kristof, K. et al 2011. Impact of molecular mimicry on the clinical course and outcome of sepsis syndrome. Mol. Immunol. 49: 512-517.
32. Buchman, A.L. et al 1995. Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. JPEN J. Parenter Enteral Nutr. 19: 453-460.
33. Chang, F. et al 2003. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17: 590-603.
34. Bouchard, V. et al 2008. B1 integrin/Fak/Src signaling in intestinal epithelial crypt cell survival: integration of complex regulatory mechanisms. Apoptosis 13: 531-542.
35. McDunn, J. et al 2008. Peptide-mediated activation of Akt and extracellular regulated kinase signaling prevents lymphocyte apoptosis. FASEB J. 22: 561-568.
36. Rexhepaj, R. et al 2007. PI3-kinase-dependent electrogenic intestinal transport of glucose and amino acids. Pflugers Arch. 453: 863-870.
37. Itoh, M. et al 1997. Involvement of ZO-1 in cadherin-based cell adhesion through its direct binding to alpha catenin and actin filaments. J. Cell Biol. 138: 181-192.
38. Zeissig, S. et al 2007. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 56: 61-72.
39. Markov, A.G. et al 2010. Segmental expression of claudin proteins correlates with tight junction barrier properties in rat intestine. J. Comp. Physiol. B. 180: 591-598.
40. Nose, K. et al 2010. Glutamine prevents total parenteral nutrition-associated changes to intraepithelial lymphocyte phenotype and function: a potential mechanism for the preservation of epithelial barrier function. J. Interferon Cytokine Res. 30: 67-80.
41. Smyth, D. et al 2011. Interferon-gamma-induced increases in intestinal epithelial macromolecular permeability requires the Src kinase Fyn. Lab Invest. 91: 764-777.
42. McKay, D.M. et al 2007. Phosphatidylinositol 3'-kinase is a critical mediator of interferon-gamma-induced increases in enteric epithelial permeability. J. Pharmacol Exp. Ther. 320: 1013-1022.
43. Cario, E., G. Gerken & D. Podolsky 2007. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132: 1359-1374.
44. Arbibe, L. et al 2000. Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat. Immunol. 1: 533-540.
45. Malo, M.S. et al 2010. Intestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota. Gut 59: 1476-1484.
46. Wildhaber, B.E. et al 2005. Lack of enteral nutrition-effects on the intestinal immune system. J. Surg. Res. 123: 8-16.
47. Yasumatsu, K. et al 2009. Multiple receptors underlie glutamate taste responses in mice. Am. J. Clin. Nutr. 90: 747S-752S.
48. Wu, S.V. et al 2002. Expression of bitter taste receptors of the T2R family in the gastrointestinal tract and enteroendocrine STC-1 cells. Proc. Natl. Acad. Sci. USA 99: 2392-2397.
49. Fujita, Y. et al 2009. Incretin release from gut is acutely enhanced by sugar but not by sweeteners in vivo. Am. J. Physiol. Endocrinol. Metab. 296: E473-E479.
50. Margolskee, R.F. et al 2007. T1R3 and gustducin in gut sense sugars to regulate expression of Na+-glucose cotransporter 1. Proc. Natl. Acad. Sci. USA 104: 15075-15080.
51. Xue, H. & C.J. Field 2011. New role of glutamate as an immunoregulator via glutamate receptors and transporters. Front Biosci. (Schol Ed). 3: 1007-1020.
52. Akiba, Y. et al 2009. Luminal L-glutamate enhances duodenal mucosal defense mechanisms via multiple glutamate receptors in rats. Am. J. Physiol. Gastrointest Liver Physiol. 297: G781-G791.
53. Wang, J.H. et al 2011. Umami receptor activation increases duodenal bicarbonate secretion via glucagon-like peptide-2 release in rats. J. Pharmacol Exp. Ther. 339: 464-473.
54. Vermeulen, M.A. et al 2011. Glutamate reduces experimental intestinal hyperpermeability and facilitates glutamine support of gut integrity. World J. Gastroenterol. 17: 1569-1573.